ICAM1 and B-cell chronic lymphocytic leukemia: Importantly, pretreatment of B-CLL cells with anti-ICAM-1 monoclonal antibodies improved both the conjugation of B-CLL cells with T cells and F-actin polymerization at the immune synapse [70].